Welcome to MutualFunds.com

Please help us personalize your experience and select the one that best describes you.

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission

We hope you enjoy your experience

Channels

Screener

Funds

Advisors

Advisor Access

News

What Medtronic's Earnings Mean for Mutual Fund Investors (MDT)

Shauna O'Brien Feb 17, 2015

Before Tuesday’s opening bell, Medtronic (MDT) released its third quarter financial results. Here’s what the results mean for mutual fund investors.

Inside MDT’s Results

Earnings

MDT reported earnings of $977 million, or 98 cents per share, up from $762 million, or 75 cents per share, a year ago. Adjusted EPS was $1.01 – above analysts’ estimate of 97 cents.

Revenue
Revenue increased to $4.318 billion from $4.163 billion last year. Analysts expected to see revenue of $4.25 billion.

Covidien Deal Will Keep Medtronic Diversified

At the end of January, Medtronic closed its $43 billion merger deal with Ireland-based Covidien. The deal will allow the company to re-incorporate in Ireland and will also provide the company with much needed diversification. This new diversification will partially offset the loss of market share in some of its businesses.

Mutual Funds to Watch

Investors interested in MDT may be interested in the funds listed below. These funds currently have the largest stakes in the company.

Symbol	Mutual Fund	Stake
VTSMX	Vanguard Total Stock Market Index	2.48%
VWNFX	Vanguard Windsor	1.86%
VFIAX	Vanguard 500 Index	1.59%

The Bottom Line

The funds listed above allow investors to gain exposure to MDT while remaining diversified. Investors interested in MDT may also be interested in St. Jude Medical (STJ) and Boston Scientific (BSX).